265 related articles for article (PubMed ID: 16246440)
1. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties.
Price MJ; Chou CC; Frantzen M; Miyamoto T; Kar S; Lee S; Shah PK; Martin BJ; Lill M; Forrester JS; Chen PS; Makkar RR
Int J Cardiol; 2006 Aug; 111(2):231-9. PubMed ID: 16246440
[TBL] [Abstract][Full Text] [Related]
2. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.
Makkar RR; Price MJ; Lill M; Frantzen M; Takizawa K; Kleisli T; Zheng J; Kar S; McClelan R; Miyamota T; Bick-Forrester J; Fishbein MC; Shah PK; Forrester JS; Sharifi B; Chen PS; Qayyum M
J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):225-33. PubMed ID: 16382259
[TBL] [Abstract][Full Text] [Related]
3. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction.
Halkos ME; Zhao ZQ; Kerendi F; Wang NP; Jiang R; Schmarkey LS; Martin BJ; Quyyumi AA; Few WL; Kin H; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2008 Nov; 103(6):525-36. PubMed ID: 18704259
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
[TBL] [Abstract][Full Text] [Related]
5. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model.
Qi CM; Ma GS; Liu NF; Shen CX; Chen Z; Liu XJ; Hu YP; Zhang XL; Teng GJ; Ju SH; Ma M; Tang YL
Chin Med J (Engl); 2008 Mar; 121(6):544-50. PubMed ID: 18364144
[TBL] [Abstract][Full Text] [Related]
7. Injection of composite with bone marrow-derived mesenchymal stem cells and a novel synthetic hydrogel after myocardial infarction: a protective role in left ventricle function.
Chen J; Guo R; Zhou Q; Wang T
Kaohsiung J Med Sci; 2014 Apr; 30(4):173-80. PubMed ID: 24656157
[TBL] [Abstract][Full Text] [Related]
8. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.
Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH
Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy with shock wave and autologous bone marrow-derived mesenchymal stem cells alleviates left ventricular dysfunction and remodeling through inhibiting inflammatory stimuli, oxidative stress & enhancing angiogenesis in a swine myocardial infarction model.
Sheu JJ; Lee FY; Yuen CM; Chen YL; Huang TH; Chua S; Chen YL; Chen CH; Chai HT; Sung PH; Chang HW; Sun CK; Yip HK
Int J Cardiol; 2015 Aug; 193():69-83. PubMed ID: 26025755
[TBL] [Abstract][Full Text] [Related]
10. Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart.
Krause U; Harter C; Seckinger A; Wolf D; Reinhard A; Bea F; Dengler T; Hardt S; Ho A; Katus HA; Kuecherer H; Hansen A
Stem Cells Dev; 2007 Feb; 16(1):31-7. PubMed ID: 17348804
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction.
Hsu WT; Jui HY; Huang YH; Su MY; Wu YW; Tseng WY; Hsu MC; Chiang BL; Wu KK; Lee CM
Cell Transplant; 2015; 24(7):1313-28. PubMed ID: 24823505
[TBL] [Abstract][Full Text] [Related]
12. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
[TBL] [Abstract][Full Text] [Related]
13. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.
Freyman T; Polin G; Osman H; Crary J; Lu M; Cheng L; Palasis M; Wilensky RL
Eur Heart J; 2006 May; 27(9):1114-22. PubMed ID: 16510464
[TBL] [Abstract][Full Text] [Related]
14. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
[TBL] [Abstract][Full Text] [Related]
16. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance.
Cheng Z; Ou L; Zhou X; Li F; Jia X; Zhang Y; Liu X; Li Y; Ward CA; Melo LG; Kong D
Mol Ther; 2008 Mar; 16(3):571-9. PubMed ID: 18253156
[TBL] [Abstract][Full Text] [Related]
17. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats.
Dai W; Hale SL; Kloner RA
Regen Med; 2007 Jan; 2(1):63-8. PubMed ID: 17465776
[TBL] [Abstract][Full Text] [Related]
18. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction.
Richardson JD; Psaltis PJ; Frost L; Paton S; Carbone A; Bertaso AG; Nelson AJ; Wong DT; Worthley MI; Gronthos S; Zannettino AC; Worthley SG
Cytotherapy; 2014 Apr; 16(4):460-70. PubMed ID: 24113430
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary Transplantation of Mesenchymal Stem Cells with Overexpressed Integrin-Linked Kinase Improves Cardiac Function in Porcine Myocardial Infarction.
Mu D; Zhang XL; Xie J; Yuan HH; Wang K; Huang W; Li GN; Lu JR; Mao LJ; Wang L; Cheng L; Mai XL; Yang J; Tian CS; Kang LN; Gu R; Zhu B; Xu B
Sci Rep; 2016 Jan; 6():19155. PubMed ID: 26750752
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
